Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Germany Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20081
20096
20102
20114
20121
20131
20142
20152
20164
20176
201810
20193
20212
20223
20234
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Recruiting8
Active, not recruiting7
Terminated6
Enrolling by invitation3
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated10
BioMarin Pharmaceutical5
Novartis Pharmaceuticals4
Novo Nordisk A/S4
GenSight Biologics3
CENTOGENE GmbH Rostock2
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2
Genzyme, a Sanofi Company2
PTC Therapeutics2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn63
Nervous System Diseases13
Musculoskeletal Diseases12
Hematologic Diseases10
Infant, Newborn, Diseases8
Metabolic Diseases8
Metabolism, Inborn Errors7
Neurodegenerative Diseases7
Eye Diseases6
Eye Diseases, Hereditary6

Trials

Showing 51 to 63 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.